Treasury makes an emergency move. North Korea fires back. A cancer cure gets one step closer.
Thursday · August 20, 2026
The Daily Digest
Dark Bulls
Bond yields at 19-year highs. Kim fires back. And a cancer vaccine that could change medicine.
The Treasury made a surprise move Wednesday to hold back a bond market that's been threatening to push mortgage rates even higher. Canada got a three-day reprieve from 50% tariffs — but the clock is already ticking again. North Korea answered Trump's peace overture with a ten-missile salute. And Moderna pulled off something that most oncologists said was years away. A full plate today.
📈 Money & Markets
The Government Is Quietly Trying to Pull the Bond Market Back From the Edge
The 30-year Treasury yield hit 5.34% last week — the highest level since 2007. Wednesday morning, the benchmark was still sitting at 5.22%. Those numbers might sound abstract, but they're not. Treasury yields are the foundation everything else is built on. Your mortgage rate. Your car loan. The return on your 401(k). When long-term government borrowing costs spike like this, the cost of money rises across the entire economy.
Treasury Secretary Scott Bessent moved Wednesday to stop the bleeding. The department announced it would at least double its bond buyback operations — from $2 billion per session to $4 billion — targeting the 10-to-30-year sector specifically. The move kicks in September 9 and runs through early November. What that means in plain English: the government is stepping into the market to buy its own debt, trying to push yields back down and stabilize borrowing costs. The announcement was unscheduled, which caught markets off guard — and yields dropped sharply on the news.
The problem is that $4 billion is a rounding error in a $32 trillion market. Analysts were quick to note the relief may be short-lived. The real drivers of elevated yields — persistent inflation, swelling federal deficits, and geopolitical uncertainty around oil — haven't gone away. The S&P 500 bounced on the news, gaining 0.31% Wednesday after three straight down days, but the market's mood remains fragile.
Bond & Market Snapshot · Aug. 20, 2026
For anyone who owns a home, is thinking about buying one, or carries variable-rate debt, the direction of these yields matters more right now than almost anything else in the news. The Fed isn't cutting rates. And the government is signaling — through this emergency buyback — that it's genuinely worried about where things are headed. That's worth paying attention to.
5.22%
30-Year Treasury Yield
4.67%
10-Year Treasury Yield
7,715
S&P 500 (Wed. close)
"The amount is negligible in a market worth $32 trillion — but the signal shows the administration's sensitivity to rising long-term borrowing costs."
— Reuters analysis, August 20, 2026
── Advertisement ──
Most financial advisors love to tell you to diversify. They want you spread across 50 different stocks, hoping for the best.
According to Market Wizard Larry Benedict, "Diversification is for dummies." When you're watching everything, you're watching nothing. Especially now, as President Trump triggers a historic regime change at the Federal Reserve.
Trillions of dollars are about to shift. And instead of scrambling to guess which sectors will win, Larry focuses on just ONE specific ticker that sits directly at the heart of Fed policy.
This exact ticker previously helped his readers capture massive double and triple-digit gains during market shocks.
Today, he's giving the name of this ticker away completely free. No guesswork. No complicated charts. Just one symbol you can trade right from your phone in under 60 seconds.
🏛️ Politics
Trump Pulled Back From the Canada Tariff Cliff — With 108 Minutes to Spare
Less than two hours before 50% tariffs were set to hit $20 billion worth of Canadian goods at midnight Tuesday, President Trump posted on Truth Social that he was hitting pause. "Canada and the U.S.A., subject to the finalization of documents, have a DEAL!" The tariffs — which would have covered everything from Canadian cheese to hockey sticks — are now on hold until August 22. That gives both sides exactly 72 hours to turn a "tentative agreement" into something with real signatures on it.
Canadian Prime Minister Mark Carney confirmed the pause while being noticeably careful about calling it a victory. He said "substantial progress" had been made and that Canada had agreed to remove certain measures seen as discriminatory toward U.S. exports — though the specifics remain unannounced. Carney is walking a domestic political tightrope: Canadians have watched the relationship with their biggest trading partner deteriorate sharply over the past year, and he can't afford to look like he's giving away the farm.
The political impact of the tariffs would have dwarfed the economic one. The $20 billion targeted represents only about 5% of what Canada sends to the U.S. each year. But Canada had promised to retaliate with levies of its own, which would have escalated a trade conflict that's already rattled supply chains and contributed to grocery price pressures on both sides of the border. Markets exhaled Wednesday — stocks rose, yields dipped — though the relief depends entirely on what happens before Friday.
This is a pattern Americans have seen before — a hard deadline, an 11th-hour deal that may or may not hold, and a short window to find out. For now, those Canadian products stay off the tariff list. Watch this space closely as the August 22 deadline approaches.
── Advertisement ──
The ink is already dry on Executive Order 14330.
Section 3, clause 4 explicitly addresses commodities and precious metals inside retirement accounts.
And inside the Federal Register, the Labor Department just confirmed that metals allow savers to benefit directly from price swings.
Over 47,000 Americans wrote in about this exact rulemaking docket.
At the same time, central banks just set an all-time record by acquiring 289 tonnes of gold in a single quarter.
The biggest institutions in the world are quietly positioning for a massive shift.
But while central banks lock away tons of bullion that pays zero interest, a $15 loophole is letting regular citizens siphon off weekly cash flow.
The schedule operates on absolute clockwork:
Declared on Wednesday.
Ex-dividend on Thursday.
Paid straight into your account on Friday. Government bureaucracy moves slowly, but the weekly payment clock does not stop.
Declared on Wednesday.
Ex-dividend on Thursday.
Paid straight into your account on Friday. Government bureaucracy moves slowly, but the weekly payment clock does not stop.
🌍 Science & World
Trump Said He Wants to Meet Kim. Kim Responded With Ten Missiles.
On Wednesday, President Trump told reporters he expected to meet North Korean leader Kim Jong Un later this year. He described the relationship as important, said it was critical to "get along" with Kim, and mentioned — apparently casually — that North Korea now has 57 "very powerful" nuclear weapons. Thursday morning, Pyongyang fired roughly ten short-range ballistic missiles from the capital region into the Sea of Japan. South Korea's military said the number was closer to ten. Officials in Seoul, meanwhile, put their own estimate of North Korea's nuclear arsenal at 80 to 120 warheads — and said they had no explanation for the gap between that figure and the president's.
The launches came one day after the U.S. scaled back its annual military drills with South Korea — a diplomatic gesture meant to signal goodwill and encourage Pyongyang back to the negotiating table. North Korea shrugged it off publicly, issued a statement dismissing the gesture, and then followed with the missile barrage. The missiles landed outside Japan's exclusive economic zone and caused no reported casualties, but the message was unmistakable.
This is North Korea's pattern, and it rarely deviates from it. Whenever the U.S. or South Korea holds military exercises — even scaled-back ones — Pyongyang treats it as a provocation and responds with tests. The concern among analysts is that Kim has far less incentive to engage diplomatically now than he did during Trump's first term. His nuclear program has advanced significantly, his relationship with Russia has grown stronger, and he faces no serious economic pressure that would force him to negotiate.
For Americans, this is a story about the limits of dealmaking with a regime that responds to olive branches with weapons fire. The discrepancy between what Trump said about North Korea's arsenal and what U.S. allies in the region are saying is also worth noting — intelligence on North Korea's capabilities matters enormously when the stakes are this high.
🧠 Health & Life · 50+
The mRNA Cancer Vaccine Just Passed Its Biggest Test. Melanoma May Never Be the Same.
Moderna and Merck announced Wednesday that their personalized mRNA cancer vaccine — called Intismeran — succeeded in a Phase 3 clinical trial for melanoma, the deadliest form of skin cancer. This is the first time a therapy of this kind has cleared that stage of testing, and it's a bigger deal than the stock surge (Moderna's shares shot up 145% in a single day) might suggest to the casual observer. In medicine, Phase 3 is where most promising treatments go to die. Getting here and winning matters.
The trial focused on patients who had already undergone surgery to remove melanoma. When Intismeran was combined with Merck's existing immunotherapy drug Keytruda, it significantly extended the time patients lived without the cancer returning — and also reduced the risk of the disease spreading to other organs. The vaccine works by analyzing a patient's own tumor and training their immune system to recognize and destroy its unique genetic markers. Every dose is essentially custom-built for one person.
Melanoma rates rise sharply after age 50, and Americans over 65 are diagnosed at nearly twice the rate of younger adults. Decades of sun exposure, weakened immune response, and slower cellular repair all contribute. This vaccine is specifically designed for high-risk patients who've had surgery — the exact demographic most likely reading this. Full data will be released at an upcoming medical conference, and the companies will share results with regulators, putting FDA review firmly on the horizon.
"This is the first randomized Phase 3 clinical trial aimed at definitively proving the benefit of neoantigen vaccines. The results could herald a new, powerful approach in oncology."
— STAT News, August 19, 2026
This is mRNA technology doing something COVID vaccines never attempted — not preventing infection, but training the body to hunt down and kill cancer cells that are already there. If this approach works across other cancer types, as researchers are now testing, the implications extend well beyond melanoma. The field just cleared its highest hurdle. What comes next will be worth watching closely.
── Advertisement ──
In a few short months, the US government could make a sweeping change to bank accounts nationwide.
It will give them unprecedented powers to control your bank account.
They could closely track every transaction... even freeze it.
Fortunately, there are 4 simple steps you can take today that could safeguard your savings.
Discover these 4 simple steps here.
Good luck and God bless!
Martin D. Weiss, PhD
Weiss Ratings Founder
Good luck and God bless!
Weiss Ratings Founder
📋 In Brief
China's Robot Maker Goes Public in the Biggest Debut of the Year
The world's leading humanoid robot manufacturer went public on a Chinese exchange this week in a blockbuster debut — shares surged dramatically on the first day of trading. The company is competing directly in a space where American firms like Tesla's robotics division have been investing heavily. For U.S. investors, the message is clear: China isn't waiting to catch up in AI-driven hardware.
The Canada Deal Clock Expires Friday. Here's What Happens If It Doesn't Stick.
The three-day tariff pause between the U.S. and Canada runs out August 22. If no final deal is signed, the 50% tariffs automatically go back into effect — and Canada has said it will retaliate with its own levies. Goods that could get caught in the crossfire include lumber, dairy products, auto parts, and Canadian beer and spirits that Americans buy regularly. The economic hit would be modest at first, but a full-blown tariff war with America's second-largest trading partner would eventually show up at checkout counters.
The Ebola Count Hits 5,000. A Quiet Reminder That Some Threats Don't Make Front Pages.
The Ebola outbreak in Central Africa passed the 5,000-case mark this week, according to international health officials. Containment efforts are ongoing, and the outbreak remains geographically concentrated — but 5,000 cases is a threshold that historically triggers more serious international coordination. Travel implications for Americans are minimal for now, though the WHO is watching closely.
— David
Dark Bulls
Published Monday–Friday
